| Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers WM Alenezi, CT Fierheller, N Recio, PN Tonin Genes 11 (8), 856, 2020 | 42 | 2020 |
| The genetic analyses of French Canadians of Quebec facilitate the characterization of new cancer predisposing genes implicated in hereditary breast and/or ovarian cancer … CT Fierheller, WM Alenezi, PN Tonin Cancers 13 (14), 3406, 2021 | 15 | 2021 |
| A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene CT Fierheller, L Guitton-Sert, WM Alenezi, T Revil, KK Oros, Y Gao, ... Genome medicine 13 (1), 1-26, 2021 | 14 | 2021 |
| The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique … WM Alenezi, L Milano, CT Fierheller, C Serruya, T Revil, KK Oros, S Behl, ... Cancers 14 (9), 2251, 2022 | 8 | 2022 |
| Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic … WM Alenezi, CT Fierheller, T Revil, C Serruya, AM Mes-Masson, ... Genes 13 (4), 697, 2022 | 6 | 2022 |
| Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases WM Alenezi, CT Fierheller, C Serruya, T Revil, KK Oros, DN Subramanian, ... Frontiers in Oncology 13, 1111191, 2023 | 2 | 2023 |
| Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene CT Fierheller, WM Alenezi, C Serruya, T Revil, S Amuzu, K Bedard, ... Genes 14 (2), 277, 2023 | 2 | 2023 |
| The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population. Cancers (Basel … WM Alenezi, L Milano, CT Fierheller, C Serruya, T Revil, KK Oros, S Behl, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 2 | 2022 |
| The genetic analysis of a founder Northern American population of European descent identifies FANCI as a candidate familial ovarian cancer risk gene CT Fierheller, L Guitton-Sert, WM Alenezi, T Revil, KK Oros, K Bedard, ... medRxiv, 2020.05. 04.20090407, 2020 | 2 | 2020 |
| Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer X Wei, L Sun, E Slade, CT Fierheller, S Oxley, A Kalra, J Sia, M Sideris, ... JAMA Network Open 7 (2), e2355324-e2355324, 2024 | 1 | 2024 |
| The genomic landscape of carriers of rare variants in FANCI, a new candidate ovarian cancer predisposing gene C Fierheller, WM Alenezi, C Serruya, T Revil, J Nadaf, AM Mes-Masson, ... Cancer Research 81 (13_Supplement), 2056-2056, 2021 | 1 | 2021 |
| Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer R Manchanda, L Sun, M Sobocan, IV Rodriguez, X Wei, A Kalra, S Oxley, ... Journal of the National Comprehensive Cancer Network 1 (aop), 1-9, 2024 | | 2024 |
| BRCA awareness and testing experience in the UK Jewish population: a qualitative study K Sarig, S Oxley, A Kalra, M Sobocan, CT Fierheller, M Sideris, T Gootzen, ... Journal of Medical Genetics, 2024 | | 2024 |
| Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D SG Oxley, X Wei, M Sideris, O Blyuss, A Kalra, JJY Sia, S Ganesan, ... Cancers 16 (7), 1358, 2024 | | 2024 |
| 443 Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer X Wei, L Sun, E Slade, C Fierheller, S Oxley, A Kalra, J Sia, M Sideris, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 405 Analysis of BRCA1 and BRCA2 information provision online TA Gootzen, A Kalra, K Sarig, M Sobocan, S Oxley, N Dworschak, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study S Oxley, J Sia, A Samuels, A Kalra, X Wei, CT Fierheller, M Sideris, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 1033 Validation of P-POSSUM scale in ovarian cancer (OC) cytoreductive surgery M Sideris, MR Brincat, O Blyuss, M Enumula, S Cyclewala, S Oxley, J Sia, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 948 EQ-5D utility scores for risk-reducing mastectomy and risk-reducing salpingo-oophorectomy: mapping from SF-12 and SF-36 S Oxley, X Wei, M Sideris, O Blyuss, A Kalra, J Sia, S Ganesan, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 406 Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation L Sun, X Wei, CT Fierheller, L Dawson, S Oxley, A Kalra, J Sia, F Feldman, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
